The research group is concerned with the study of the molecular mechanisms of angiogenesis (in neovascular retinopathies and tumors ) and tumor development . Within the group there is also an active line of translational research aimed at the development of bioactive molecules with anti angiogenesis and anti tumor functions.
Computer simulation of spectroscopy and chemical and photochemical reactivity at the molecular level. Computer simulation of the activation of biological photoreceptors and fluorescent proteins.
The research activities of the group are focused on the development, preparation, and characterization of intelligent nanomaterials, particularly: development of polysaccharide and lipid-based nanocarriers. development of tissue substitutes. drafting of analysis protocols. conformational and dynamic analysis of biomolecules
The resarch activities are dealing with high resolution electron microscopy studies on the functional morhology of eukariotic cell organelles with particular focus on cell motility and control of the cell cycle.
The research activity is focused on basic research projects based on the ONE HEALTH principle . The activity mainly aims to evaluate the benefits for human health of compounds extracts of ornamental plants or foods with particular attention to the principles of local biodiversity and bioeconomy
The research activities of the BioStructLab are focus on gene manipulation by recombinant DNA technique, production of biological macromolecules ( RNA and DNA), and structural characterization by structural biology techniques The
The research group is focused on two key areas, synthetic organic chemistry and computational chemistry, which are highly complementary and in complete synergy with each other. the research group is interested in the development of new chemical methodologies in the medicinal chemistry context and in the study of the interaction between the drug and its macromolecular target
The invention consists of a smart, inexpensive and biocompatible nanomaterial with custom-designed bioactivity.
The extracorporeal clearance precision measurement system allows clearance rate of extracorporeal treatments to be measured in real time and adjusted to patients’ needs.
The invention consists of a nanofunctionalized device that enables the quantitative determination of a specific biomarker, the FKBP12 protein, involved in many diseases.
